Prevalence and genotype distribution of high-risk Human Papillomavirus infection among Vietnamese women in Ho Chi Minh City, Viet Nam: A population-based cross-sectional study

被引:2
作者
Nguyet, Ho Minh [1 ]
Tam, Phan Thanh [2 ]
Ung, Quach Kim [3 ]
Kien, To Gia [4 ]
Phuoc, Le Hong [4 ]
机构
[1] Ho Chi Minh City Ctr Dis Control, Dept Nutr & Noncommunicable Dis, Ho Chi Minh City, Vietnam
[2] Dist 10 Hlth Ctr, Ho Chi Minh City, Vietnam
[3] Binh Thanh Dist Hlth Ctr, Ho Chi Minh City, Vietnam
[4] Univ Med & Pharm Ho Chi Minh City, Fac Publ Hlth, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam
关键词
Human Papilomavirus; High-risk HPV infection; HPV genotype; Viet Nam; KNOWLEDGE; STUDENTS; VACCINE; VIRUS; HANOI;
D O I
10.1016/j.gore.2024.101526
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Persistent infection with high-risk Human Papillomavirus (HR-HPV) genotypes are wellknown to increase the risk of cervical cancer significantly. This study aims to determine the prevalence and distribution of high-risk HR-HPV genotypes among women in Ho Chi Minh City (HCMC), Viet Nam. Methods: A population-based cross-sectional study was conducted between June 2020 and September 2020 in all 24 districts of HCMC, Viet Nam. Socio-demographic and behavioral data were collected from 2478 women aged 25 to 65 who had sexual intercourse using a self-administered questionnaire. Vaginal swab specimens from all participants were collected to identify HR-HPV genotypes using Polymerase Chain Reaction (PCR) protocols. Results: The prevalence of HR-HPV infection was 3.5 % (87 women, including 20 cases infected with multi- genotypes), 3.1 % in urban and 0.4 % in rural areas. The most detected HR-HPV genotypes among positive cases were 58 (25.3 %), 52 (21.8 %), 16(21.8 %), 68 (10.3 %), 51 (10.34 %) and 18 (9.2 %). The prevalence of multi-type HR-HPV genotypes was 0.81 %, of which the most common co-infection genotypes were 52 and 58 (20.0 %), 16 and 56 (10.0 %), and 16 and 39 (10.0 %). The percentages of one-, two-, three-, and four-genotypes of HPV among positive cases were 77.0 %, 16.1 %, 4.6 % and 2.3 %, respectively. Conclusions: Our findings explore a low prevalence of HR-HPV infection in Vietnamese women, of which genotypes 52 and 58 are more popular than 16 and 18. Continuously updated data on the genotype distribution of HPV are helpful for vaccine development and planning preventive activities to prevent HPV-related cancers.
引用
收藏
页数:7
相关论文
共 37 条
[1]  
[Anonymous], 2024, Sacace Biotechnologies HPV Genotypes 14 Real-TM Quant
[2]   Distribution of HPV Genotypes Differs Depending on Behavioural Factors among Young Women [J].
Bergqvist, Laura ;
Kalliala, Ilkka ;
Aro, Karoliina ;
Auvinen, Eeva ;
Jakobsson, Maija ;
Kiviharju, Mari ;
Virtanen, Seppo ;
Dillner, Joakim ;
Nieminen, Pekka ;
Louvanto, Karolina .
MICROORGANISMS, 2021, 9 (04)
[3]  
Bruni L., 2019, HUMAN PAPILLOMAVIRUS
[4]   Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings [J].
Bruni, Laia ;
Diaz, Mireia ;
Castellsague, Xavier ;
Ferrer, Elena ;
Bosch, F. Xavier ;
de Sanjose, Silvia .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (12) :1789-1799
[5]   Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis [J].
de Martel, Catherine ;
Georges, Damien ;
Bray, Freddie ;
Ferlay, Jacques ;
Clifford, Gary M. .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E180-E190
[6]   Human papillomavirus vaccine disease impact beyond expectations [J].
de Sanjose, Silvia ;
Brotons, Maria ;
LaMontagne, D. Scott ;
Bruni, Laia .
CURRENT OPINION IN VIROLOGY, 2019, 39 :16-22
[7]   Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis [J].
Dorji, Thinley ;
Nopsopon, Tanawin ;
Tamang, Saran Tenzin ;
Pongpirul, Krit .
ECLINICALMEDICINE, 2021, 34
[8]   Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [J].
Drolet, Melanie ;
Benard, Elodie ;
Perez, Norma ;
Brisson, Marc ;
Boily, Marie-Claude ;
Ali, Hammad ;
Baldo, Vincenzo ;
Brassard, Paul ;
Brotherton, Julia M. L. ;
Callander, Denton ;
Checchi, Marta ;
Chow, Eric P. F. ;
Cocchio, Silvia ;
Dalianis, Tina ;
Deeks, Shelley L. ;
Dehlendorff, Christian ;
Donovan, Basil ;
Fairley, Christopher K. ;
Flagg, Elaine W. ;
Gargano, Julia W. ;
Garland, Suzanne M. ;
Grun, Nathalie ;
Hansen, Bo T. ;
Harrison, Christopher ;
Herweijer, Eva ;
Imburgia, Teresa M. ;
Johnson, Anne M. ;
Kahn, Jessica A. ;
Kavanagh, Kimberley ;
Kjaer, Susanne K. ;
Kliewer, Erich V. ;
Liu, Bette ;
Machalek, Dorothy A. ;
Markowitz, Lauri ;
Mesher, David ;
Munk, Christian ;
Niccolai, Linda ;
Nygard, Mari ;
Ogilvie, Gina ;
Oliphant, Jeannie ;
Pollock, Kevin G. ;
Purrinos-Hermida, Maria Jesus ;
Smith, Megan A. ;
Steben, Marc ;
Soderlund-Strand, Anna ;
Sonnenberg, Pam ;
Sparen, Par ;
Tanton, Clare ;
Wheeler, Cosette M. ;
Woestenberg, Petra J. .
LANCET, 2019, 394 (10197) :497-509
[9]  
Dung T.C., 2017, Vietnam. J. Prev. Med., V27, P11
[10]   Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective [J].
Ebrahimi, Narges ;
Yousefi, Zahra ;
Khosravi, Gholamreza ;
Malayeri, Fatemeh Eskandari ;
Golabi, Marjan ;
Askarzadeh, Monireh ;
Shams, Mohammad Hossein ;
Ghezelbash, Behrooz ;
Eskandari, Nahid .
FRONTIERS IN IMMUNOLOGY, 2023, 14